Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 26, 2023

SELL
$50.96 - $58.72 $254 - $293
-5 Reduced 0.82%
606 $33,000
Q1 2023

Apr 12, 2023

BUY
$35.33 - $55.79 $17,841 - $28,173
505 Added 476.42%
611 $34,000
Q4 2022

Jan 24, 2023

SELL
$24.4 - $41.3 $12,200 - $20,650
-500 Reduced 82.51%
106 $0
Q3 2022

Oct 13, 2022

BUY
$28.48 - $52.59 $15,379 - $28,398
540 Added 818.18%
606 $17,000
Q2 2022

Jul 28, 2022

SELL
$36.95 - $82.41 $8,276 - $18,459
-224 Reduced 77.24%
66 $3,000
Q4 2021

Jan 24, 2022

BUY
$135.05 - $182.59 $39,164 - $52,951
290 New
290 $43,000

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.5B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track National Bank Of Canada Portfolio

Follow National Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of National Bank Of Canada , based on Form 13F filings with the SEC.

News

Stay updated on National Bank Of Canada with notifications on news.